seedfolio Archived Investments
FUND 2 INVESTMENTS
Kinathera is developing a novel oral inhibitor of type 1 interferon to treat auto-immune diseases.
Tiamat is using plants to produce mammalian proteins at low cost and high scale for cultured meats and biotech.
Xeno Biosciences is tackling the massive obesity epidemic with a revolutionary pill.
FUND 1b INVESTMENTS
Developing an anti-toxin (not antibiotic) to stop c. difficile in its tracks
Selling a novel sensing device for hydraulic systems to grealy reduce unplanned maintenance and fluid spills
Developing lab-grown meat with low-cost breakthroughs. Pork without pain.
None